Richmond Pharmacology ishonoured to be attending the 2024 Annual Meeting of the Japanese Society ofClinical Pharmacology and Therapeutics (JSCPT). This event in Omiya bringstogether leading clinical pharmacologists to discuss the latest advancements indrug development and therapeutic innovation. The conference will featurevarious
scientific sessions, posterpresentations, and networking opportunities.
To connect with our teamduring the event, please reach out to arrange a meeting.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
